GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

GLP-1 has also become popular when used as a weight loss drug. But, experts warn there can be side effects if taken incorrectly. In 2024, the Alabama Poison Information Center saw a major increase in ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

GLP-1 receptor agonist use before pregnancy was tied to ... Now, we know what the potential effect size of these drugs might be. Now, let’s document in a prospective study that improved ...

Hair loss was not a reported side effect of Mounjaro, but it was reported with other GLP-1 agonists. Mounjaro can cause side effects, such as nausea, vomiting, and diarrhea. But, hair loss was not ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.